Neural Bases for Addictive Properties of Benzodiazepines

Overview

Journal Nature

Specialty Science

Date 2010 Feb 12

PMID 20148031

Citations 165

Authors

Kelly R Tan

Matthew Brown

Gwenael Labouebe

Cedric Yvon

Cyril Creton

Jean-Marc Fritschy

Uwe Rudolph

Christian Luscher

Affiliations

Soon will be listed here.

Abstract

Benzodiazepines are widely used in clinics and for recreational purposes, but will lead to addiction in vulnerable individuals. Addictive drugs increase the levels of dopamine and also trigger long-lasting synaptic adaptations in the mesolimbic reward system that ultimately may induce the pathological behaviour. The neural basis for the addictive nature of benzodiazepines, however, remains elusive. Here we show that benzodiazepines increase firing of dopamine neurons of the ventral tegmental area through the positive modulation of GABA(A) (gamma-aminobutyric acid type A) receptors in nearby interneurons. Such disinhibition, which relies on alpha1-containing GABA(A) receptors expressed in these cells, triggers drug-evoked synaptic plasticity in excitatory afferents onto dopamine neurons and underlies drug reinforcement. Taken together, our data provide evidence that benzodiazepines share defining pharmacological features of addictive drugs through cell-type-specific expression of alpha1-containing GABA(A) receptors in the ventral tegmental area. The data also indicate that subunit-selective benzodiazepines sparing alpha1 may be devoid of addiction liability.

Citing Articles

Shifting perspectives: an investigation of a virtual reality awe experience in people going through cancer treatment.

Tao V, Tennant G, Clayden C, Reynolds L Support Care Cancer. 2025; 33(2):136.

PMID: 39891780 PMC: 11787277. DOI: 10.1007/s00520-025-09192-4.

Chronic ethanol exposure in mice evokes pre- and postsynaptic deficits in GABAergic transmission in ventral tegmental area GABA neurons.

Mitten E, Souders A, Marron Fernandez de Velasco E, Aguado C, Lujan R, Wickman K Br J Pharmacol. 2024; 182(1):69-86.

PMID: 39358985 PMC: 11831720. DOI: 10.1111/bph.17335.

Co-administration of midazolam and psilocybin: differential effects on subjective quality versus memory of the psychedelic experience.

Nicholas C, Banks M, Lennertz R, Wenthur C, Krause B, Riedner B Transl Psychiatry. 2024; 14(1):372.

PMID: 39266503 PMC: 11393325. DOI: 10.1038/s41398-024-03059-8.

Benzodiazepine use for anxiety disorders is associated with increased long-term risk of mood and substance use disorders: A large-scale retrospective cohort study.

Sun C, Pola A, Su K, Lin B, Kablinger A, Trestman R Drug Alcohol Depend Rep. 2024; 12:100270.

PMID: 39247100 PMC: 11380165. DOI: 10.1016/j.dadr.2024.100270.

Antinociceptive Effects of 2/3-Subtype-Selective GABA Receptor Positive Allosteric Modulators KRM-II-81 and NS16085 in Male Rats: Behavioral Specificity.

Lewter L, Woodhouse K, Tiruveedhula V, Cook J, Li J J Pharmacol Exp Ther. 2024; 391(3):389-398.

PMID: 38670800 PMC: 11585310. DOI: 10.1124/jpet.123.002070.

References

Mohler H, Benke D, Mertens S, Fritschy J . GABAA-receptor subtypes differing in alpha-subunit composition display unique pharmacological properties. Adv Biochem Psychopharmacol. 1992; 47:41-53. View

Fuchs V, Burbes E, Coper H . The influence of haloperidol and aminooxyacetic acid on etonitazene, alcohol, diazepam and barbital consumption. Drug Alcohol Depend. 1984; 14(2):179-86. DOI: 10.1016/0376-8716(84)90043-7. View

Low K, Crestani F, Keist R, Benke D, Brunig I, Benson J . Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 2000; 290(5489):131-4. DOI: 10.1126/science.290.5489.131. View

Yerbury R, Cooper S . Novel benzodiazepine receptor ligands: palatable food intake following zolpidem, CGS 17867A, or Ro23-0364, in the rat. Pharmacol Biochem Behav. 1989; 33(2):303-7. DOI: 10.1016/0091-3057(89)90504-2. View

OBrien C . Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005; 66 Suppl 2:28-33. View

Pilotto R, Singer G, Overstreet D . Self-injection of diazepam in naive rats: effects of dose, schedule and blockade of different receptors. Psychopharmacology (Berl). 1984; 84(2):174-7. DOI: 10.1007/BF00427442. View

Johnson S, North R . Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol. 1992; 450:455-68. PMC: 1176131. DOI: 10.1113/jphysiol.1992.sp019136. View

Morris H, Nilsson S, Dixon C, Stephens D, Clifton P . Alpha1- and alpha2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagia. Appetite. 2009; 52(3):675-683. DOI: 10.1016/j.appet.2009.03.006. View

Sigel E, Schaerer M, Buhr A, Baur R . The benzodiazepine binding pocket of recombinant alpha1beta2gamma2 gamma-aminobutyric acidA receptors: relative orientation of ligands and amino acid side chains. Mol Pharmacol. 1998; 54(6):1097-105. DOI: 10.1124/mol.54.6.1097. View

10.

Yee B, Keist R, von Boehmer L, Studer R, Benke D, Hagenbuch N . A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proc Natl Acad Sci U S A. 2005; 102(47):17154-9. PMC: 1288020. DOI: 10.1073/pnas.0508752102. View

11.

Mameli M, Halbout B, Creton C, Engblom D, Parkitna J, Spanagel R . Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc. Nat Neurosci. 2009; 12(8):1036-41. DOI: 10.1038/nn.2367. View

12.

Heikkinen A, Moykkynen T, Korpi E . Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists. Neuropsychopharmacology. 2008; 34(2):290-8. DOI: 10.1038/npp.2008.89. View

13.

Arendt R, Greenblatt D, Liebisch D, Luu M, Paul S . Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity. Psychopharmacology (Berl). 1987; 93(1):72-6. DOI: 10.1007/BF02439589. View

14.

Tamamaki N, Yanagawa Y, Tomioka R, Miyazaki J, Obata K, Kaneko T . Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol. 2003; 467(1):60-79. DOI: 10.1002/cne.10905. View

15.

Saal D, Dong Y, Bonci A, Malenka R . Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron. 2003; 37(4):577-82. DOI: 10.1016/s0896-6273(03)00021-7. View

16.

Hsia A, Malenka R, Nicoll R . Development of excitatory circuitry in the hippocampus. J Neurophysiol. 1998; 79(4):2013-24. DOI: 10.1152/jn.1998.79.4.2013. View

17.

Klitenick M, DeWitte P, Kalivas P . Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci. 1992; 12(7):2623-32. PMC: 6575858. View

18.

Luscher C, Bellone C . Cocaine-evoked synaptic plasticity: a key to addiction?. Nat Neurosci. 2008; 11(7):737-8. DOI: 10.1038/nn0708-737. View

19.

Rowlett J, Platt D, Lelas S, Atack J, Dawson G . Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci U S A. 2005; 102(3):915-20. PMC: 545524. DOI: 10.1073/pnas.0405621102. View

20.

Long P, Mercer A, Begum R, Stephens G, Sihra T, Jovanovic J . Nerve Terminal GABAA Receptors Activate Ca2+/Calmodulin-dependent Signaling to Inhibit Voltage-gated Ca2+ Influx and Glutamate Release. J Biol Chem. 2009; 284(13):8726-37. PMC: 2659231. DOI: 10.1074/jbc.M805322200. View